Sygnature Chemical Services, a leading provider of premium medicinal chemistry and computational chemistry services to the global pharmaceutical industry, and Heptares Therapeutics, a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), have announced that they have
